Gian Paolo Rossi Selected Research

Oxygen (Dioxygen)

1/2019	Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy.
10/2016	Randomised sham-controlled trial of transcutaneous electrical stimulation in obstructive sleep apnoea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gian Paolo Rossi Research Topics

Disease

85	Hyperaldosteronism (Conn Syndrome) 03/2024 - 07/2002
79	Hypertension (High Blood Pressure) 03/2024 - 02/2002
60	Adenoma (Adenomas) 05/2024 - 02/2006
13	Neoplasms (Cancer) 01/2022 - 03/2006
13	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 03/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 02/2002
11	Hypokalemia 03/2024 - 04/2008
10	Essential Hypertension 12/2023 - 07/2008
10	Hyperplasia 09/2019 - 04/2004
9	Atherosclerosis 11/2017 - 11/2003
8	Heart Failure 11/2022 - 01/2003
7	Pheochromocytoma 11/2023 - 03/2006
7	Hypertrophy 06/2016 - 02/2002
6	Fibrosis (Cirrhosis) 03/2016 - 02/2003
5	Stroke (Strokes) 01/2022 - 01/2003
5	Body Weight (Weight, Body) 10/2008 - 02/2002
4	Chronic Renal Insufficiency 12/2023 - 01/2016
4	Inflammation (Inflammations) 12/2023 - 03/2016
4	Adrenocortical Carcinoma 05/2023 - 03/2005
4	Overweight 01/2018 - 03/2003
3	Addison Disease (Addison's Disease) 11/2023 - 09/2022
3	COVID-19 10/2023 - 01/2020
3	Renovascular Hypertension (Goldblatt Syndrome) 11/2022 - 05/2002
3	Familial Hyperaldosteronism 01/2022 - 09/2016
3	Gitelman Syndrome 08/2018 - 02/2014
3	Pre-Eclampsia (Preeclampsia) 01/2018 - 02/2013
3	Vascular Remodeling 01/2018 - 01/2003
3	Hypotension (Low Blood Pressure) 11/2015 - 04/2004
2	Chronic Disease (Chronic Diseases) 12/2023 - 01/2016
2	Pulmonary Embolism 10/2023 - 01/2022
2	Paraganglioma (Paragangliomas) 10/2022 - 01/2022
2	Cushing Syndrome 10/2022 - 01/2022
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 09/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 05/2006
2	Left Ventricular Dysfunction 01/2022 - 01/2007
2	Hypovolemia 01/2021 - 12/2019
2	Atrial Fibrillation 11/2019 - 01/2018
2	Hyperparathyroidism 01/2019 - 08/2012
2	Channelopathies 12/2018 - 09/2014
2	Airway Obstruction (Choking) 01/2018 - 10/2016
2	Hyperhomocysteinemia 01/2018 - 04/2005
2	Obstructive Sleep Apnea 01/2018 - 11/2016

Drug/Important Bio-Agent (IBA)

83	AldosteroneIBA 05/2024 - 07/2002
26	ReninIBA 01/2023 - 05/2002
15	Angiotensin IIIBA 05/2022 - 02/2002
9	Endothelins (Endothelin)IBA 01/2023 - 01/2003
9	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 03/2006
8	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 10/2013
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2004
8	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 05/2008
7	SodiumIBA 12/2023 - 08/2007
7	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 05/2023 - 12/2007
6	Messenger RNA (mRNA)IBA 12/2023 - 03/2006
6	Hormones (Hormone)IBA 12/2023 - 01/2018
6	PotassiumIBA 01/2021 - 09/2014
5	MineralocorticoidsIBA 01/2021 - 09/2006
5	AngiotensinsIBA 01/2021 - 05/2002
5	HomocysteineIBA 12/2008 - 01/2005
5	MDL 100240IBA 07/2006 - 02/2002
4	AcidsIBA 05/2023 - 04/2014
4	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022 - 02/2006
4	Type 1 Angiotensin ReceptorIBA 05/2022 - 02/2014
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2022 - 07/2002
4	Peptides (Polypeptides)IBA 01/2021 - 05/2002
4	Captopril (Capoten)FDA LinkGeneric 01/2019 - 12/2006
4	Endothelin-1 (Endothelin 1)IBA 01/2018 - 02/2002
4	Ramipril (Altace)FDA LinkGeneric 07/2006 - 02/2002
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2004 - 03/2003
3	CanrenoneIBA 12/2023 - 01/2019
3	SteroidsIBA 12/2023 - 10/2022
3	Cosyntropin (Cortrosyn)FDA LinkGeneric 03/2020 - 01/2017
3	AutoantibodiesIBA 10/2019 - 02/2013
3	AntioxidantsIBA 11/2015 - 01/2013
3	EnzymesIBA 11/2015 - 11/2003
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2015 - 01/2012
3	oxidized low density lipoproteinIBA 06/2014 - 10/2003
3	LDL Lipoproteins (beta Lipoproteins)IBA 09/2013 - 11/2003
3	Irbesartan FDA LinkGeneric 10/2008 - 07/2002
3	AdiponectinIBA 10/2008 - 06/2006
3	CollagenIBA 02/2003 - 07/2002
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2024 - 12/2014
2	SaltsIBA 12/2023 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2022
2	GlucocorticoidsIBA 09/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2015
2	NormetanephrineIBA 01/2022 - 10/2021
2	CytokinesIBA 01/2022 - 11/2017
2	Androstenedione (4 Androstene 3,17 dione)IBA 10/2021 - 01/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 04/2004
2	olmesartanIBA 01/2020 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 10/2016
2	MacrolidesIBA 01/2018 - 12/2017
2	Metoclopramide (Reglan)FDA LinkGeneric 01/2018 - 11/2016
2	AntigensIBA 11/2017 - 03/2010

Therapy/Procedure

38	Adrenalectomy 12/2023 - 03/2002
14	Therapeutics 09/2022 - 09/2006
5	Continuous Positive Airway Pressure 01/2018 - 06/2014
3	Nephrectomy 06/2006 - 03/2002
2	Denervation 01/2022 - 07/2013